Vividion Therapeutics Begins U.S. IPO Effort
sanjeri/E+ via Getty Images
Quick Take
Vividion Therapeutics (VVID) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.
The company is a preclinical stage biopharma discovering treatment candidates…
